Continuous Infusion Versus Intermittent Boluses of Cisatracurium in the Early Management of Pediatric ARDS

NCT05153525 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Respiratory Distress Syndrome, Pediatric
Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)

Interventions

DRUG: Intermittent boluses of Cisatracurium
DRUG: Intravenous infusion of Cisatracurium for 24 hours

Sponsor

Tanta University